{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20231115",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "77169",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/218213Orig1s000TOC.html",
              "date": "20231229",
              "type": "Review"
            },
            {
              "id": "77170",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/218213s000lbl.pdf",
              "date": "20231116",
              "type": "Label"
            },
            {
              "id": "77171",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/218213Orig1s000ltr.pdf",
              "date": "20231116",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20240613",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "78797",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218213s001lbl.pdf",
              "date": "20240613",
              "type": "Label"
            },
            {
              "id": "78801",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/218213Orig1s001ltr.pdf",
              "date": "20240614",
              "type": "Letter"
            },
            {
              "id": "80451",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2024/218213Orig1s001.pdf",
              "date": "20241129",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA218213",
      "sponsor_name": "BRISTOL",
      "openfda": {
        "application_number": [
          "NDA218213"
        ],
        "brand_name": [
          "AUGTYRO"
        ],
        "generic_name": [
          "REPOTRECTINIB"
        ],
        "manufacturer_name": [
          "E.R. Squibb & Sons, L.L.C."
        ],
        "product_ndc": [
          "0003-4040",
          "0003-4160"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "REPOTRECTINIB"
        ],
        "rxcui": [
          "2670649",
          "2670655",
          "2696876",
          "2696878"
        ],
        "spl_id": [
          "03987a7d-5ac9-4c41-9a48-c9aee4dd13de"
        ],
        "spl_set_id": [
          "fb526827-40ba-4462-94cf-179ae3b0cb8a"
        ],
        "package_ndc": [
          "0003-4040-60",
          "0003-4040-12",
          "0003-4160-14",
          "0003-4160-60"
        ],
        "nui": [
          "N0000175605",
          "N0000194093",
          "N0000194094",
          "N0000194095",
          "N0000194096",
          "N0000185506"
        ],
        "pharm_class_epc": [
          "Kinase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]",
          "Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]",
          "Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]",
          "Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]",
          "Cytochrome P450 3A4 Inducers [MoA]"
        ],
        "unii": [
          "08O3FQ4UNP"
        ]
      },
      "products": [
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "AUGTYRO",
          "active_ingredients": [
            {
              "name": "REPOTRECTINIB",
              "strength": "160MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "CAPSULE",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "AUGTYRO",
          "active_ingredients": [
            {
              "name": "REPOTRECTINIB",
              "strength": "40MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "CAPSULE",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}